Inflammatory Bowel Disease: Why Should I Take My Medications?

The content of this FREE virtual lecture was derived from a live, educational teleconference presented by the Crohn’s & Colitis Foundation of America on Thursday, March 6, 2008.

The virtual lecture format enables you to:

See presentation slides and hear the audio at the same time
Download a transcript of the presentation
Download a copy of the presentation slides

Nursing professionals can participate in the learning assessment and complete an Evaluation form to receive
continuing nursing education credit.

Patients and caregivers can participate by completing
an Evaluation form to help us plan for future educational
activities.

RELEASE: March 6, 2008
CNE AVAILABLE UNTIL: March 6, 2009
MEDIUM: Virtual Lecture
Estimated time to complete this activity: 1 hour

Sunanda V. Kane, MD, MSPH
Associate Professor of Medicine
Mayo Clinic College of Medicine
Rochester, Minnesota

This activity has been designed to meet the educational needs of nursing professionals who are involved in the diagnosis, treatment, and education of patients with inflammatory bowel disease (IBD).

To complete this activity and receive a Statement of Credit, participants must:

Review all contents of this activity
Complete and submit the Learning Assessment and Evaluation form
Score at least 70% on the Learning Assessment

There is no fee for this educational activity.

NOTE. Participants in the live teleconference entitled Inflammatory Bowel Disease: Why Should I Take My Medications? are not permitted to receive credit for this activity.

This activity is intended to assist nursing professionals in understanding the latest advances in the treatment of inflammatory bowel disease and the importance of medication adherence.

An estimated 1.4 million people in the United States have been diagnosed with some form of inflammatory bowel disease (IBD).¹ IBD, which includes ulcerative colitis and Crohn's disease, is a chronic condition that can lead to colorectal cancer when left untreated.² Unfortunately, optimal treatment of IBD can be difficult to achieve. High-grade evidence for appropriate therapeutic management of Crohn's disease is lacking in current research.³ Moreover, management of IBD requires a consistent, daily treatment regimen, yet 20% to 40% of patients report non-adherence to their IBD medication.^2,4 Factors associated with non-adherence vary significantly between studies, but often include gender, lifestyle, and presence of symptoms.^2,4,5 Currently, there is a need to educate patients and healthcare professionals on the most recent findings regarding IBD medication management and adherence.

¹Sanderson JD, Parkes GC. Timing of surgery for inflammatory bowel disease. BMJ. 2007;335:1006.
²D'Incá R, Bertomoro P, Mazzocco K, et al. Risk factors for non-adherence to medication in inflammatory bowel disease patients. Ailment Pharmacol Ther. 2008;27:166-172.
³Vader JP, Froehlich F, Juillerat P. Appropriate treatment for Crohn's disease: methodology and summary results of a multidisciplinary international expert panel approach – EPACT. Digestion. 2006;73:237-248.
⁴Ediger JP, Walker JR, Graff L, et al. Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol. 2007;102:1417-1426.
⁵Cerveny P, Bortlik M, Kubena A, et al. Nonadherence in inflammatory bowel disease: results of factor analysis. Inflamm Bowel Dis. 2007;13:1244-1249.

After completing this activity, the participant should be better able to:

Describe symptoms of inflammatory bowel disease
List medications used to treat inflammatory bowel disease
Explain the goals of therapy for inflammatory bowel disease
Cite factors that contribute to medication non-adherence
Identify issues that could arise as a result of non-adherence
Recount practical strategies to help patients adhere to medication

This continuing education program is cosponsored by Robert Michael Educational Institute LLC and Postgraduate Institute for Medicine, in collaboration with the Crohn's & Colitis Foundation of America, and is supported by an educational grant from Procter & Gamble Pharmaceuticals.

ACCREDITATION STATEMENT
CNA/ANCC
This educational activity for 1.0 contact hour is provided by Postgraduate Institute for Medicine (PIM).

PIM is an approved provider of continuing education by the Colorado Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

CALIFORNIA BOARD OF REGISTERED NURSING
Postgraduate Institute for Medicine is approved by the California Board of Registered Nursing, Provider Number 13485 for 1.25 contact hours.

A statement of credit will be issued only upon receipt of a completed activity Evaluation form and will be mailed to you in 4 to 6 weeks.

Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interest related to the content of this CME activity:

• Dr. Sunanda V. Kane: Consultant and Contracted Research: Procter & Gamble Pharmaceuticals and Shire

The following planners and managers have the following to disclose:

Robert Michael Educational Institute LLC

• Sherri Kramer, MD, has no affiliations with commercial interests to disclose.

Postgraduate Institute for Medicine

• Jan Hixon, RN, BSN, MA, has no affiliations with commercial interests to disclose.
• Linda Graham, RN, has no affiliations with commercial interests to disclose.
• Trace Hutchison, PharmD, has no affiliations with commercial interests to disclose.

Sunanda V. Kane, MD, MSPH, is Associate Professor of Medicine at the Mayo Clinic College of Medicine in Rochester, Minnesota. She received her medical training at Rush-Presbyterian–St. Luke's Medical College in Chicago, Illinois, and completed her fellowship training at the University of Chicago, Pritzker School of Medicine. Dr. Kane also holds a Master's degree in biostatistics and epidemiology. Her work includes caring for patients with inflammatory bowel disease, and her areas of interest include gender-specific issues in gastroenterology and medication adherence.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information and comparison with recommendations of other authorities.

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Postgraduate Institute for Medicine (PIM), Robert Michael Educational Institute LLC and the Crohn's & Colitis Foundation of America do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, Robert Michael Educational Institute LLC and the Crohn's & Colitis Foundation of America. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

There is no fee for this educational activity.

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity: jjones@pimed.com. For technical assistance, contact jungsen@rmcom.net.

Hardware/Software requirements include:
• Windows 95, 98se, ME, XP, NT 4.0, 2000
  - Internet Explorer 4.0+
  - Netscape Navigator 6.2+
  - AOL 8
  - Mozilla Firefox 1.0+
• Macintosh 9.2, OS X 10.1+
  - Safari 1.1+
  - Netscape Navigator 6.2+
  - Internet Explorer 5/2+
  - Mozilla Firefox 1.0+
• Additional Requirements
  - Macromedia Flash Player 7
  - Internal/external speakers
  - Broadband connection (DSL/cable) recommended

For more information about the Crohn’s & Colitis Foundation of America, visit www.ccfa.org.

PIM Privacy Policy RMEI Privacy Statement


Home	Start Lecture Presentation	Enter Learning Assessment & Evaluation form	Download Presentation Slides
The content of this FREE virtual lecture was derived from a live, educational teleconference presented by the Crohn’s & Colitis Foundation of America on Thursday, March 6, 2008. The virtual lecture format enables you to: See presentation slides and hear the audio at the same time Download a transcript of the presentation Download a copy of the presentation slides Nursing professionals can participate in the learning assessment and complete an Evaluation form to receive continuing nursing education credit. Patients and caregivers can participate by completing an Evaluation form to help us plan for future educational activities. RELEASE: March 6, 2008 CNE AVAILABLE UNTIL: March 6, 2009 MEDIUM: Virtual Lecture Estimated time to complete this activity: 1 hour Sunanda V. Kane, MD, MSPH Associate Professor of Medicine Mayo Clinic College of Medicine Rochester, Minnesota This activity has been designed to meet the educational needs of nursing professionals who are involved in the diagnosis, treatment, and education of patients with inflammatory bowel disease (IBD). To complete this activity and receive a Statement of Credit, participants must: Review all contents of this activity Complete and submit the Learning Assessment and Evaluation form Score at least 70% on the Learning Assessment There is no fee for this educational activity. NOTE. Participants in the live teleconference entitled Inflammatory Bowel Disease: Why Should I Take My Medications? are not permitted to receive credit for this activity. This activity is intended to assist nursing professionals in understanding the latest advances in the treatment of inflammatory bowel disease and the importance of medication adherence. An estimated 1.4 million people in the United States have been diagnosed with some form of inflammatory bowel disease (IBD).¹ IBD, which includes ulcerative colitis and Crohn's disease, is a chronic condition that can lead to colorectal cancer when left untreated.² Unfortunately, optimal treatment of IBD can be difficult to achieve. High-grade evidence for appropriate therapeutic management of Crohn's disease is lacking in current research.³ Moreover, management of IBD requires a consistent, daily treatment regimen, yet 20% to 40% of patients report non-adherence to their IBD medication.^2,4 Factors associated with non-adherence vary significantly between studies, but often include gender, lifestyle, and presence of symptoms.^2,4,5 Currently, there is a need to educate patients and healthcare professionals on the most recent findings regarding IBD medication management and adherence. ¹Sanderson JD, Parkes GC. Timing of surgery for inflammatory bowel disease. BMJ. 2007;335:1006. ²D'Incá R, Bertomoro P, Mazzocco K, et al. Risk factors for non-adherence to medication in inflammatory bowel disease patients. Ailment Pharmacol Ther. 2008;27:166-172. ³Vader JP, Froehlich F, Juillerat P. Appropriate treatment for Crohn's disease: methodology and summary results of a multidisciplinary international expert panel approach – EPACT. Digestion. 2006;73:237-248. ⁴Ediger JP, Walker JR, Graff L, et al. Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol. 2007;102:1417-1426. ⁵Cerveny P, Bortlik M, Kubena A, et al. Nonadherence in inflammatory bowel disease: results of factor analysis. Inflamm Bowel Dis. 2007;13:1244-1249. After completing this activity, the participant should be better able to: Describe symptoms of inflammatory bowel disease List medications used to treat inflammatory bowel disease Explain the goals of therapy for inflammatory bowel disease Cite factors that contribute to medication non-adherence Identify issues that could arise as a result of non-adherence Recount practical strategies to help patients adhere to medication This continuing education program is cosponsored by Robert Michael Educational Institute LLC and Postgraduate Institute for Medicine, in collaboration with the Crohn's & Colitis Foundation of America, and is supported by an educational grant from Procter & Gamble Pharmaceuticals. ACCREDITATION STATEMENT CNA/ANCC This educational activity for 1.0 contact hour is provided by Postgraduate Institute for Medicine (PIM). PIM is an approved provider of continuing education by the Colorado Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. CALIFORNIA BOARD OF REGISTERED NURSING Postgraduate Institute for Medicine is approved by the California Board of Registered Nursing, Provider Number 13485 for 1.25 contact hours. A statement of credit will be issued only upon receipt of a completed activity Evaluation form and will be mailed to you in 4 to 6 weeks. Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest. The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interest related to the content of this CME activity: • Dr. Sunanda V. Kane: Consultant and Contracted Research: Procter & Gamble Pharmaceuticals and Shire The following planners and managers have the following to disclose: Robert Michael Educational Institute LLC • Sherri Kramer, MD, has no affiliations with commercial interests to disclose. Postgraduate Institute for Medicine • Jan Hixon, RN, BSN, MA, has no affiliations with commercial interests to disclose. • Linda Graham, RN, has no affiliations with commercial interests to disclose. • Trace Hutchison, PharmD, has no affiliations with commercial interests to disclose. Sunanda V. Kane, MD, MSPH, is Associate Professor of Medicine at the Mayo Clinic College of Medicine in Rochester, Minnesota. She received her medical training at Rush-Presbyterian–St. Luke's Medical College in Chicago, Illinois, and completed her fellowship training at the University of Chicago, Pritzker School of Medicine. Dr. Kane also holds a Master's degree in biostatistics and epidemiology. Her work includes caring for patients with inflammatory bowel disease, and her areas of interest include gender-specific issues in gastroenterology and medication adherence. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information and comparison with recommendations of other authorities. This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Postgraduate Institute for Medicine (PIM), Robert Michael Educational Institute LLC and the Crohn's & Colitis Foundation of America do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, Robert Michael Educational Institute LLC and the Crohn's & Colitis Foundation of America. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. There is no fee for this educational activity. For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity: jjones@pimed.com. For technical assistance, contact jungsen@rmcom.net. Hardware/Software requirements include: • Windows 95, 98se, ME, XP, NT 4.0, 2000 - Internet Explorer 4.0+ - Netscape Navigator 6.2+ - AOL 8 - Mozilla Firefox 1.0+ • Macintosh 9.2, OS X 10.1+ - Safari 1.1+ - Netscape Navigator 6.2+ - Internet Explorer 5/2+ - Mozilla Firefox 1.0+ • Additional Requirements - Macromedia Flash Player 7 - Internal/external speakers - Broadband connection (DSL/cable) recommended For more information about the Crohn’s & Colitis Foundation of America, visit www.ccfa.org. PIM Privacy Policy RMEI Privacy Statement
© Content Copyright 2008. Crohn’s & Colitis Foundation of America. All rights reserved. Program Developed and Managed by Robert Michael Educational Institute LLC 101 Laurel Road \| Voorhees, New Jersey 08043 \| www.rmei.com \| (856) 547-4141